Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Quantum Genomics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Quantum Genomics SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Quantum Genomics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Quantum Genomics SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Quantum Genomics SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Quantum Genomics SA, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Quantum Genomics Enters into Research Agreement with University of Ottawa Heart Institute and Center for Interdisciplinary Research in Biology 11
Quantum Genomics Enters into Co-Development Agreement for QGC101 12
Equity Offering 13
Quantum Genomics to Raise USD7.4 Million in First Tranche of Private Placement of Shares 13
Quantum Genomics Raises USD9.6 Million in Private Placement of Shares 14
Quantum Genomics Raises USD3.4 Million in Public Offering of Shares 15
Quantum Genomics Raises USD6 Million in Private Placement of Shares 16
Quantum Genomics Completes Underwriters Exercise of Over-Allotment Option of IPO for USD14.4 Million 17
Quantum Genomics Raises Additional USD0.33 Million in Private Placement of Shares 19
Quantum Genomics Raises USD4.7 Million in Private Placement of Shares 20
Debt Offering 21
Quantum Genomics Raises USD3.7 Million in Public Offering of Bonds 21
Quantum Genomics SA – Key Competitors 22
Quantum Genomics SA – Key Employees 23
Quantum Genomics SA – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Strategy And Business Planning 25
Apr 19, 2018: Quantum Genomics enters a new phase of maturity with its BAPAIs Fast Growth strategic plan 25
Financial Announcements 28
Mar 29, 2018: Quantum Genomics publishes its financial results for the year 2017 28
Oct 03, 2017: Quantum Genomics Releases 2017 First-Half Financial Results and First Nine Months Business Update 30
Mar 30, 2017: Quantum Genomics: 2016 annual financial results 32
Corporate Communications 34
Apr 09, 2018: Quantum Genomics strengthens its governance 34
Feb 05, 2018: Quantum Genomics strengthens its Scientific Advisory Board with the appointment of Professor Frans Leenen, a renowned expert in congestive heart failure 35
Jul 11, 2017: Quantum Genomics begins trading in the U.S. on OTCQX 36
Jun 30, 2017: Quantum Genomics appoints Professor Toshiro Fujita as member of its Scientific Advisory Board 37
Apr 25, 2017: Quantum Genomics appoints Bruno Besse as Chief Medical Officer 38
Product News 39
10/27/2017: Quantum Genomics receives the Galien MedStartUp award for the innovative design of its NEW-HOPE study 39
10/16/2017: Quantum Genomics nominated for the Galien MedStartUp Award for the innovative design of its NEW-HOPE trial 40
06/04/2018: FIRIBASTAT Approved as Common International Name for QGC001 by World Health Organization 41
Clinical Trials 42
Nov 15, 2017: Quantum Genomics announces recruitment of first patients in the NEW-HOPE arterial hypertension study in the United States 42
Sep 05, 2017: Quantum Genomics Receives FDA Clearance of IND Application for QGC001 43
Jun 28, 2017: Quantum Genomics announces the design of its next Phase II trial in arterial hypertension, NEW-HOPE 44
Jun 19, 2017: Quantum Genomics details positive results from its Phase IIa trial of QGC001 for the treatment of arterial hypertension 46
May 09, 2017: Quantum Genomics will organize a teleconference on June 19, 2017, to comment on phase IIa data in high blood pressure 48
Mar 14, 2017: Quantum Genomics announces positive data from new preclinical studies with QGC001 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50
Quantum Genomics SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Quantum Genomics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Quantum Genomics SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Quantum Genomics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Quantum Genomics SA, Deals By Therapy Area, 2012 to YTD 2018 9
Quantum Genomics SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Quantum Genomics Enters into Research Agreement with University of Ottawa Heart Institute and Center for Interdisciplinary Research in Biology 11
Quantum Genomics Enters into Co-Development Agreement for QGC101 12
Quantum Genomics to Raise USD7.4 Million in First Tranche of Private Placement of Shares 13
Quantum Genomics Raises USD9.6 Million in Private Placement of Shares 14
Quantum Genomics Raises USD3.4 Million in Public Offering of Shares 15
Quantum Genomics Raises USD6 Million in Private Placement of Shares 16
Quantum Genomics Completes Underwriters Exercise of Over-Allotment Option of IPO for USD14.4 Million 17
Quantum Genomics Raises Additional USD0.33 Million in Private Placement of Shares 19
Quantum Genomics Raises USD4.7 Million in Private Placement of Shares 20
Quantum Genomics Raises USD3.7 Million in Public Offering of Bonds 21
Quantum Genomics SA, Key Competitors 22
Quantum Genomics SA, Key Employees 23
List of Figures
Quantum Genomics SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Quantum Genomics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Quantum Genomics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Quantum Genomics SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Quantum Genomics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Quantum Genomics SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Quantum Genomics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Quantum Genomics SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9